Soligenix(SNGX)
PRINCETON, NJ
BiotechnologyFocus: Lipoprotein Delivery, Small Molecules
Soligenix is a life sciences company focused on Lipoprotein Delivery, Small Molecules.
OncologyGastroenterologyImmunology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
SGX201
EnteritisClinical Trials (1)
NCT01073384A Dose Ranging Study of Delayed Release Beclomethasone for Prevention of Acute Enteritis in Patients With Rectal Cancer
Phase 1/2Hypericin
Cutaneous T Cell LymphomaClinical Trials (1)
NCT05872854Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light
Phase 2Hypericin
PsoriasisClinical Trials (1)
NCT05442190Topical SGX302 for Mild-to-Moderate Psoriasis
Phase 2Phase 2
Clinical Trials (1)
NCT05380635PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma
Phase 2SGX942
Oral MucositisClinical Trials (1)
NCT02013050A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer
Phase 2Phase 2
Clinical Trials (1)
NCT01925950Study of orBec® as Monotherapy in the Treatment of Patients With Upper GI Symptoms Caused by Chronic Graft Versus Host Disease (GVHD)
Phase 2Phase 2
Clinical Trials (1)
NCT06149247HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL
Phase 2Dusquetide
Behçet DiseaseClinical Trials (1)
NCT06386744Dusquetide for the Treatment of Behcet's Disease
Phase 2Phase 3
Clinical Trials (1)
NCT02448381FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
Phase 3Clinical Trials (1)
NCT03237325DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer
Phase 3oral beclomethasone 17,21-dipropionate
Acute Gastrointestinal Graft vs Host DiseaseClinical Trials (1)
NCT00926575Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)
Phase 3Hypericin
CTCL/ Mycosis FungoidesClinical Trials (1)
NCT06470451Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 12 clinical trials
Top TAs: Oncology, Gastroenterology, Immunology
Publications: 25 in PubMed
SEC Filings: 2 available
Therapeutic Area Focus
Marketed
Pipeline